Hypoxium has been acquired by Horizon Discovery, and will now be trading as Horizon Discovery Services, a wholly-owned subsidiary of Horizon Discovery.
Please view the Press Release or visit the Horizon Discovery website for more information.
About Horizon Discovery Services
Horizon Discovery Services is a contract research organization specializing in cell biology within the oncology therapeutic area. Using our expertise in drug discovery and oncology translational research, we assist biotechnology and pharmaceutical companies to rapidly and successfully progress their lead compounds.
Core services
- Compound screening in cellular assays
- Development of bespoke cell assays to fit your requirements
- Support, interpretation and understanding of oncology cell biology
- Provision of dedicated cell biology resource
Click here for more details.